Log in to save to my catalogue

Next-Generation Sequencing-Based Preimplantation Genetic Testing for De Novo NF1 Mutations

Next-Generation Sequencing-Based Preimplantation Genetic Testing for De Novo NF1 Mutations

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_9763981

Next-Generation Sequencing-Based Preimplantation Genetic Testing for De Novo NF1 Mutations

About this item

Full title

Next-Generation Sequencing-Based Preimplantation Genetic Testing for De Novo NF1 Mutations

Publisher

Seoul: The Korean BioChip Society (KBCS)

Journal title

BioChip Journal, 2021, 15(1), , pp.69-76

Language

English

Formats

Publication information

Publisher

Seoul: The Korean BioChip Society (KBCS)

More information

Scope and Contents

Contents

Neurofibroma type 1 (NFI) is an autosomal dominant genetic disease associated with cancer and cognitive dysfunction. The 50% de novo mutation rate and numerous mutation types of the
NF1
gene pose challenges to preimplantation genetic testing (PGT) for NFI. In 2020, a couple was subjected to next-generation sequencing (NGS)-based PGT at our ce...

Alternative Titles

Full title

Next-Generation Sequencing-Based Preimplantation Genetic Testing for De Novo NF1 Mutations

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_9763981

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_9763981

Other Identifiers

ISSN

1976-0280

E-ISSN

2092-7843

DOI

10.1007/s13206-021-00006-3

How to access this item